United Kingdom · Question · Written question
UIN 1189
Cystic Fibrosis: Pancreatic Enzyme Replacement Therapy
Introduced
23 July 2024
Last action
26 July 2024 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
26 July 2024
Summary
To ask the Secretary of State for Health and Social Care, if he will take steps to ensure the supply of pancreatic enzyme replacement therapies for people with cystic fibrosis.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
23 July 2024
Written question
To ask the Secretary of State for Health and Social Care, if he will take steps to ensure the supply of pancreatic enzyme replacement therapies for people with cystic fibrosis.
Source: Commons
26 July 2024
Answer
The Department has been working with suppliers to address current supply issues with pancreatic enzyme replacement therapy (PERT), including Creon, used in the treatment of cystic fibrosis and certain cancers, including pancreatic cancer. The supply issue...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2024-07-23/1189
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1722822
- uk · wq-1722822 · source updated 26 July 2024